George Yu

Nessuna posizione attualmente

51 anni

Health Technology

Consumer Services

Technology Services

Profilo

George Yu is the founder of Medisun Precision Medicine Ltd.
founded in 2012, where he held the titles of President, Chief Executive Officer, CFO & Director from 2014 to 2017.
He was also the President, Chief Executive Officer, CFO & Director of Logiq, Inc. in 2012 and the Chief Financial Officer & Director of SinoBiomed, Inc. from 2010 to 2011.
Dr. Yu holds a doctorate from Eberhard Karls Universität Tübingen and an MBA from Columbia Business School.

Precedenti posizioni note di George Yu

Società	Posizione	Fine
MEDISUN PRECISION MEDICINE LTD.	Amministratore Delegato	19/01/2017
SinoBiomed, Inc. SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products.	Presidente	16/06/2011
LOGIQ, INC.	Presidente	20/12/2012

Vedi nel dettaglio l'esperienza di George Yu

Formazione di George Yu

Eberhard Karls Universität Tübingen	Doctorate Degree
Columbia Business School	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di George Yu

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
LOGIQ, INC.	Technology Services

Aziende private	2
Medisun Precision Medicine Ltd. Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands.	Health Technology
SinoBiomed, Inc. SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products.	Health Technology